Skip to main content

Table 2 Treatment characteristics of the patients

From: Concurrent chemoradiotherapy with low dose weekly gemcitabine in stage III non-small cell lung cancer

Variable

Number (n)

Percentage (%)

RT Planning

  

   Conventional

8

36.4

   Conformal

14

63.6

RT Dose/Fraction

  

   1.8 Gy

13

59.1

   2 Gy

9

40.9

Number of RT Treatment Weeks

  

   4

1

4.5

   5–7

16

72.7

   ≥8

5

22.7

Number of G Treatment Weeks

  

   ≤4

7

31.8

   5–7

13

59.1

   ≥8

2

9.1

  1. RT: Radiotherapy, G: Gemcitabine
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us